Company: EDSA
Filing Date: 2025-05-28
Form Type: 8-K
Source: 0001171843-25-003495
Chunk: 2

Company: Edesa Biotech, Inc.
Filing Date: 2025-05-28
Form: 8-K
Item: Item 9.01
Chunk 2
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                      
 ────────────────────────────────────────────────────────────────────────────────────────────────────
  10.1*            Amendment No. 4 to Edesa Biotech, Inc. 2019 Equity Incentive Compensation Plan.  
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document).     

* Management contract or compensatory plan or arrangement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                          Edesa Biotech, Inc.                               
  Date: May 28, 2025      By:                      /s/ Peter Weiler         
                          Name:                    Peter Weiler             
                          Title:                   Chief Financial Officer